LadRx

LADX · OTC

$0.00+$0.0001 (−100.00%)TodayMarket closed ·
No price history for this range.

Latest news

  • NewsVandana Singh

    Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

  • Press releaseBusiness Wire

    LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.